AI Biopsy: Neural Networks Find Cirrhosis via DNA Fragments

On March 6, 2026, ScienceDaily published a breakthrough study in medical machine learning. Scientists have developed a "liquid biopsy" system where AI analyzes specific DNA fragments (cfDNA) directly in the patient's blood.

Until now, diagnosing early-stage liver fibrosis and cirrhosis required invasive intervention (puncture) or expensive hardware examinations, which often had a margin of error. Trained on thousands of samples, the neural network detects microscopic patterns of cell destruction long before clinical symptoms appear. This is a turning point for preventive medicine: shifting heavy mathematical analysis from labs to the cloud radically reduces the cost of diagnostics and potentially saves millions of lives.

Source: ScienceDaily